Expert Profile

Share QR code Edit Profile

Mark Brantly

Professor

MD-MOLECULAR GENTCS / MICROBIO | COLLEGE-MEDICINE

View:

Select
All (all in one) Research Terms and Keywords Publications Co-Investigator Network Websites Contact

All
Research
Publications
Network
Websites
Contact

Research Terms & Keywords

Research Terms

Medical Sciences

Industries

Health Care

Research Projects

Ends

Title

01-2025

Kamada 008 Study Task Order #1 Kamada 008 Study Task Order #1

KAMAD

08-2024

Takeda Consulting Agreement Takeda Consulting Agreement

TAKEDA DEVELOPMENT CENTER AMERICAS INC

06-2024

Alpha-1 Coded Testing (ACT) Study Alpha-1 Coded Testing (ACT) Study

ALPHA ONE FO

06-2024

Alpha-1 Foundation DNA and Tissue Bank 7/1/2019 to 6/30/2020 Alpha-1 Foundation DNA and Tissue Bank 7/1/2019 to 6/30/2020

ALPHA ONE FO

01-2024

INHIBRX Advisory Meeting INHIBRX Advisory Meeting

INHIBRX

01-2024

Intellia Consulting Agreement Intellia Consulting Agreement

INTELLIA THERAPEUTICS

12-2023

Novel biomarkers for alpha 1-antitrypsin mediated liver disease in circulating exosomes Novel biomarkers for alpha 1-antitrypsin mediated liver disease in circulating exosomes

ALPHA ONE FO

03-2023

Liver and AAT Deficiency Liver and AAT Deficiency

UNIV OF FLORID

02-2023

BAL Testing for Inhibrx rhAAT-Fc (INBRX-101) BAL Testing for Inhibrx rhAAT-Fc (INBRX-101)

INHIBRX

12-2022

A high concentration of a-defensins impairs macrophage differentiation and function in AATD individuals A high concentration of a-defensins impairs macrophage differentiation and function in AATD individuals

ALPHA ONE FO

12-2022

01040902 01040902

BAYER GROU

12-2022

01040902 01040902

Grifols

10-2022

Dicerna Pharmaceuticals Consulting Agreement Dicerna Pharmaceuticals Consulting Agreement

DICERNA PHARMACEUTICALS

10-2022

Vertex AAT Steering Committee Agreement Vertex AAT Steering Committee Agreement

VERTEX PHARMACEUTICAL

09-2022

Adverum AAT Testing (ADVM-043-01) Adverum AAT Testing (ADVM-043-01)

ADVERUM BIOTECHNOLOGIES INC

06-2022

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease Subcontract Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease Subcontract

COLUMBIA UNIVERSIT

06-2022

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease Subcontract Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease Subcontract

NATL INST OF HLTH NHLB

12-2021

Apic Bio Research Agreement Apic Bio Research Agreement

APIC BIO

10-2021

A Master Protocol Assessing The Safety, Tolerability, And Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 A Master Protocol Assessing The Safety, Tolerability, And Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19

BIOMEDICAL ADVANCED RES & DEVLPMT AUTHOR

10-2021

REGENERON PHARMACEUTICAL

09-2021

Dicerna A1AT-101 Study Dicerna A1AT-101 Study

DICERNA PHARMACEUTICALS

06-2021

CTSI Institutional Support CTSI Institutional Support

MULTIPLE SPONSOR

06-2021

CTSI Institutional Support CTSI Institutional Support

UF DIV OF SPONSORED RES MATCHING FUND

06-2021

Pulmonary Med Cystic Fibrosis Pulmonary Med Cystic Fibrosis

UF FO

03-2021

An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19 An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19

BIOMEDICAL ADVANCED RES & DEVLPMT AUTHOR

03-2021

REGENERON PHARMACEUTICAL

12-2020

CTSI CTSI

MULTIPLE SPONSOR

12-2020

CTSI CTSI

UF DIV OF SPONSORED RES MATCHING FUND

12-2020

CTSI CTSI

UF RESEARCH FO

11-2020

Brantly MD, Mark CAG (AAT Steering Committee) Brantly MD, Mark CAG (AAT Steering Committee)

VERTEX PHARMACEUTICAL

10-2020

Quintiles Independent Contractor Agreement - Protocol 471101 (Quintiles Project Code: JXA36454) Quintiles Independent Contractor Agreement - Protocol 471101 (Quintiles Project Code: JXA36454)

QUINTILES IN

08-2020

Takeda Consultant Project Services Agreement (PSA) | US Alpha-1 #Medical Advisory Board | Mark Brantly Takeda Consultant Project Services Agreement (PSA) | US Alpha-1 #Medical Advisory Board | Mark Brantly

SHIRE HUMAN GENETIC THERAPIES INC

06-2020

Alpha One Professorship UFF Fund 7320 Alpha One Professorship UFF Fund 7320

UF FO

05-2020

Alpha 1 Liver Biopsy Slides Alpha 1 Liver Biopsy Slides

ARROWHEAD RESEARCH CORPORATIO

03-2020

The Role of Conformational Diseases on Macrophage Function The Role of Conformational Diseases on Macrophage Function

UNIV OF FLORID

03-2020

Lung Transplant Research Fund UFF 8263 Lung Transplant Research Fund UFF 8263

UF FO

01-2020

Alpha-1 Research Program Multiple Sponsors Project Alpha-1 Research Program Multiple Sponsors Project

MULTIPLE SPONSOR

12-2019

Kamada Consulting Master Agreement Kamada Consulting Master Agreement

KAMAD

10-2019

Vertex Advisory Board Agreement for AATD Liver Disease Advisory Board July 18, 2019 Vertex Advisory Board Agreement for AATD Liver Disease Advisory Board July 18, 2019

VERTEX PHARMACEUTICAL

06-2019

Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage

FL CLINICAL PRACTICE ASS

06-2019

Alpha-1 Foundation DNA and Tissue Bank Agreement 2016-2019 Alpha-1 Foundation DNA and Tissue Bank Agreement 2016-2019

ALPHA ONE FO

06-2019

THE EFFECT OF OBESITY ON IMMUNE RESPONSES IN PNEUMOCOCCALPOLYSACCHARIDE VACCINE THE EFFECT OF OBESITY ON IMMUNE RESPONSES IN PNEUMOCOCCALPOLYSACCHARIDE VACCINE

FL CLINICAL PRACTICE ASS

02-2019

Vertex Consulting Agreement Vertex Consulting Agreement

VERTEX PHARMACEUTICAL

09-2018

Assay Validation Service for Inhibrx Phase 1 Clinical Study of rhAAT-FC (INBRX-101) Assay Validation Service for Inhibrx Phase 1 Clinical Study of rhAAT-FC (INBRX-101)

INHIBRX

10-2017

A Multi-center, Randomized, Double-blind, Crossover Study to Assess the Safety and Pharmacokinetics of Liquid Alpha1-Proteinase Inhibitor (Human) Compared to Prolastin-? C in Subjects with Alpha1-Antitrypsin Deficiency A Multi-center, Randomized, Double-blind, Crossover Study to Assess the Safety and Pharmacokinetics of Liquid Alpha1-Proteinase Inhibitor (Human) Compared to Prolastin-? C in Subjects with Alpha1-Antitrypsin Deficiency

Grifols

04-2017

Phase II, double-blind, placebo-controlled study to explore the ELF and plasma concentration as well as safety of Inhaled Alpha-1 Antitrypsin in Alpha-1 Antitrypsin Deficiency subjects Phase II, double-blind, placebo-controlled study to explore the ELF and plasma concentration as well as safety of Inhaled Alpha-1 Antitrypsin in Alpha-1 Antitrypsin Deficiency subjects

KAMAD

01-2017

Alpha-1 Antitrypsin in African Americans and Hispanics Alpha-1 Antitrypsin in African Americans and Hispanics

ALPHA ONE FO

01-2017

Alpha-1 Antitrypsin in African Americans and Hispanics Alpha-1 Antitrypsin in African Americans and Hispanics

UNIV OF VIRGINI

12-2016

Kamada-inhaled 006 Laboratory Testing Service Agreement Kamada-inhaled 006 Laboratory Testing Service Agreement

KAMAD

12-2016

Kamada 007-EU Laboratory Testing Service Agreement for A1RP-INST-AAT-007 Kamada 007-EU Laboratory Testing Service Agreement for A1RP-INST-AAT-007

KAMAD

12-2016

Reference Laboratory for "A Multiple-Site, Phase 2, Safety and Efficacy Trial of a Recombinant Adeno-associated Virus Vector Expressing Alpha-1 Antitrypsin (rAAV1-CB-hAAT) in Patients with Alpha-1 Antitrypsin Deficiency Reference Laboratory for "A Multiple-Site, Phase 2, Safety and Efficacy Trial of a Recombinant Adeno-associated Virus Vector Expressing Alpha-1 Antitrypsin (rAAV1-CB-hAAT) in Patients with Alpha-1 Antitrypsin Deficiency

APPLIED GENETICS TECH COR

07-2016

Alpha-1 Antirypsin Deficiency: Understanding and Alpha-1 Antirypsin Deficiency: Understanding and

FL CLINICAL PRACTICE ASS

07-2016

A Randomized, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin A Randomized, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin

TALECRIS BIOTHERAPEUTIC

06-2016

Alpha-1 Foundation DNA and Tissue Bank 13-16 Alpha-1 Foundation DNA and Tissue Bank 13-16

ALPHA ONE FO

06-2016

ACT Program Testing Service Grant Agreement ACT Program Testing Service Grant Agreement

ALPHA ONE FO

06-2016

State of Florida Testing Service Grant Agreement State of Florida Testing Service Grant Agreement

ALPHA ONE FO

01-2016

An Open-Label Extension Study of the Long Term Safety of An Open-Label Extension Study of the Long Term Safety of

INTERMUNE IN

10-2015

Intermune PIPF-031 Intermune PIPF-031

INTERMUNE IN

08-2015

The Effect of Short-Term Atorvastatin Treatment on Immun The Effect of Short-Term Atorvastatin Treatment on Immun

FL CLINICAL PRACTICE ASS

07-2015

LRRI Testing LRRI Testing

LOVELACE BIOMED & ENVIRONMENTAL RES INS

06-2015

Stromedix-003_Brantly_Randomized, Double-Blind, Placebo Stromedix-003_Brantly_Randomized, Double-Blind, Placebo

STROMEDI

03-2015

BMS-986020-Brantly BMS-986020-Brantly

BRISTOL MYERS SQUIBB C

01-2015

AAT Lab Services Agreement - HICL AAT Lab Services Agreement - HICL

HOSPITALS IN-COMMON LABORATORY IN

09-2014

PIPF-016: A Randomized, Double Blind, Placebo-Controlled PIPF-016: A Randomized, Double Blind, Placebo-Controlled

COVANCE IN

06-2014

UF Adult Cystic Fibrosis Center-Acct CC109-13AD UF Adult Cystic Fibrosis Center-Acct CC109-13AD

CYSTIC FIBROSIS FO

06-2014

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

10-2013

Talecris SPARK STUDY:A Multi-center, Randomized, Double- Talecris SPARK STUDY:A Multi-center, Randomized, Double-

TALECRIS BIOTHERAPEUTIC

06-2013

UF Adult Cystic Fibrosis Center-Acct C023-12AD UF Adult Cystic Fibrosis Center-Acct C023-12AD

CYSTIC FIBROSIS FO

06-2013

ACT Program Testing Service Grant Agreement ACT Program Testing Service Grant Agreement

ALPHA ONE FO

06-2013

State of Florida Testing Service Grant Agreement State of Florida Testing Service Grant Agreement

ALPHA ONE FO

12-2012

A 52-Week, Double-Blind, Randomized, Placebo-Controlled, A 52-Week, Double-Blind, Randomized, Placebo-Controlled,

FOREST LABORATORIES IN

08-2012

THE ALPHA-1 FOUNDATION QUANTUM-1 STUDY THE ALPHA-1 FOUNDATION QUANTUM-1 STUDY

ALPHA ONE FO

06-2012

UF Adult Cystic Fibrosis Center UF Adult Cystic Fibrosis Center

CYSTIC FIBROSIS FO

06-2012

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

06-2011

Center of Excellence in Lung Transplantation Center of Excellence in Lung Transplantation

FL CLINICAL PRACTICE ASS

06-2011

UF Adult Cystic Fibrosis Center UF Adult Cystic Fibrosis Center

CYSTIC FIBROSIS FO

06-2011

MILES Trial MILES Trial

UNIV OF CINCINNAT

05-2011

NAC40630 NAC40630

CHILDRENS HOSP SEATTL

05-2011

Talecris Reconciliation Letter for BREATH Study Talecris Reconciliation Letter for BREATH Study

TALECRIS BIOTHERAPEUTIC

02-2011

Aztreonam Aztreonam

GILEAD SCIENCE

12-2010

Targeted Detection of Alpha-1 Antitrypsin Deficiency in Targeted Detection of Alpha-1 Antitrypsin Deficiency in

ALPHA ONE FO

12-2010

Targeted Detection of Alpha-1 Antitrypsin Deficiency in Targeted Detection of Alpha-1 Antitrypsin Deficiency in

ALPHA ONE FO

12-2010

Preclinical and Phase I/II Trials of AAV1-AAT Vectors Preclinical and Phase I/II Trials of AAV1-AAT Vectors

APPLIED GENETICS TECH COR

10-2010

Phase II/III Randomized Double-Blind Comparison of Alpha Phase II/III Randomized Double-Blind Comparison of Alpha

KAMAD

07-2010

Quantitative chest computed tomography Unmasking Emphyse Quantitative chest computed tomography Unmasking Emphyse

LAM FO

06-2010

Washington University- Senior AAT Lab Services Agreement Washington University- Senior AAT Lab Services Agreement

WASHINGTON UNI

06-2010

ACT Program Testing Service Grant Agreement ACT Program Testing Service Grant Agreement

ALPHA ONE FO

06-2010

Alpha-1 Florida Detection Program Alpha-1 Florida Detection Program

ALPHA ONE FO

06-2010

The Multicenter International Lymphangioleiomyomatosis The Multicenter International Lymphangioleiomyomatosis

LAM FO

03-2010

PIPF-006, A Randomized, Double-Blind, Placebo-Controlled PIPF-006, A Randomized, Double-Blind, Placebo-Controlled

INTERMUNE IN

01-2010

Laboratory Services Agreement for Kamada s Phase II/III Laboratory Services Agreement for Kamada s Phase II/III

BIOSOLUTIONS GROU

01-2010

GENETIC MODIFIERS OF THE ALPHA 1-ANTITRYPSIN DEFICIENCY GENETIC MODIFIERS OF THE ALPHA 1-ANTITRYPSIN DEFICIENCY

ALPHA ONE FO

12-2009

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

09-2009

Therapeutic small molecules for alpha-1antitrypsin defic Therapeutic small molecules for alpha-1antitrypsin defic

ALPHA ONE FO

05-2009

A Phase 4 Study to evaluate the effect of weekly augment A Phase 4 Study to evaluate the effect of weekly augment

BAXTER HEALTHCARE COR

01-2009

HIV/AAT Laboratory Service Agreement HIV/AAT Laboratory Service Agreement

ST VINCENTS CATHOLIC MEDICAL CENTER

12-2008

Alpha-1 State of Florida Detection Program Alpha-1 State of Florida Detection Program

ALPHA ONE FO

12-2008

Reference Laboratory for the Alpha-1 Coded Tested Trial Reference Laboratory for the Alpha-1 Coded Tested Trial

ALPHA ONE FO

06-2008

Alpha-1 Antitrypsin Genetics Laboratory Service Agreemen Alpha-1 Antitrypsin Genetics Laboratory Service Agreemen

WASHINGTON UNI

06-2008

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

05-2008

Multi-center, randomized, double blind crossover trial Multi-center, randomized, double blind crossover trial

TALECRIS BIOTHERAPEUTIC

05-2008

Multi-center, open-label trial to evaluate the safety Multi-center, open-label trial to evaluate the safety

TALECRIS BIOTHERAPEUTIC

03-2008

Preclinical and Phase I/II Trials of AAV-AAT Vectors Preclinical and Phase I/II Trials of AAV-AAT Vectors

UNIV OF MASSACHUSETT

03-2008

PRECLINICAL and PHASE I/II TRIALS OF AAV-AAT VECTORS PRECLINICAL and PHASE I/II TRIALS OF AAV-AAT VECTORS

NATL INST OF HLTH NHLB

12-2007

Alpha-1 State of Florida Detection Program Alpha-1 State of Florida Detection Program

ALPHA ONE FO

12-2007

Reference Laboratory for the Alpha-1 Coded Tested Trial Reference Laboratory for the Alpha-1 Coded Tested Trial

ALPHA ONE FO

07-2007

THE ANTI-INFLAMMATORY ROLE OF ALPHA-1 ANTITRYPSIN IN THE THE ANTI-INFLAMMATORY ROLE OF ALPHA-1 ANTITRYPSIN IN THE

NATL INST OF HLTH NHLB

06-2007

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

03-2007

TOBACCO SMOKE INDUCED CELL INJURY IN LUNG COMPARTMENT TOBACCO SMOKE INDUCED CELL INJURY IN LUNG COMPARTMENT

FL DEPT OF HLT

12-2006

Alpha-1 State of Florida Detection Program Alpha-1 State of Florida Detection Program

ALPHA ONE FO

09-2006

Alpha-1 State of Florida Detection Program Alpha-1 State of Florida Detection Program

ALPHA ONE FO

09-2006

Reference Laboratory for the Alpha-1 Coded Tested Trial Reference Laboratory for the Alpha-1 Coded Tested Trial

ALPHA ONE FO

06-2006

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

06-2006

NEUTROPHIL APOPTOSIS AND NEONATAL INFLAMMATION NEUTROPHIL APOPTOSIS AND NEONATAL INFLAMMATION

NATL INST OF HLT

06-2006

MAPPING THE ROLE OF UNFOLDED PROTEIN RESPONSE GENES IN MAPPING THE ROLE OF UNFOLDED PROTEIN RESPONSE GENES IN

ALPHA ONE FO

03-2006

A PHASE 1B/2A STUDY TO EVALUATE THE EFFECT OF A PHASE 1B/2A STUDY TO EVALUATE THE EFFECT OF

BAXTER HEALTHCARE COR

03-2006

4-PHENYL BUTYRATE MEDIATED SECRETION RESCUE IN ALPHA 1-A 4-PHENYL BUTYRATE MEDIATED SECRETION RESCUE IN ALPHA 1-A

ALPHA ONE FO

02-2006

PHASE 1B/2A..AEROSOLIZED, RECOMBINANT ALPHA-1ANTITRYPSIN PHASE 1B/2A..AEROSOLIZED, RECOMBINANT ALPHA-1ANTITRYPSIN

BAXTER HEALTHCARE COR

12-2005

Alpha-1 State of Florida Detection Program Alpha-1 State of Florida Detection Program

ALPHA ONE FO

12-2005

Reference Laboratory for the Alpha-1 Coded Tested Trial Reference Laboratory for the Alpha-1 Coded Tested Trial

ALPHA ONE FO

10-2005

PHASE I SAFETY INVESTIGATION OF AN AEROLIZED, RECOMBINAN PHASE I SAFETY INVESTIGATION OF AN AEROLIZED, RECOMBINAN

BAXTER HEALTHCARE COR

09-2005

FINE MAPPING OF COPD SUSCEPTIBILITY GENES FINE MAPPING OF COPD SUSCEPTIBILITY GENES

BRIGHAM AND WOMEN'S HOSPITA

09-2005

ALPHA-1 FOUNDAITON DNA AND TISSUE BANK ALPHA-1 FOUNDAITON DNA AND TISSUE BANK

ALPHA ONE FO

07-2005

ALPHA-1 ANTITRYPSIN DEFICIENCY LABORATORY ALPHA-1 ANTITRYPSIN DEFICIENCY LABORATORY

ALPHA ONE FO

07-2005

RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES

NATL INST OF HLTH NIDD

06-2005

Alpha-1 Foundation DNA and Tissue Bank Alpha-1 Foundation DNA and Tissue Bank

ALPHA ONE FO

09-2004

LABORATORY SERVICES AGREEMENT LABORATORY SERVICES AGREEMENT

AVENTI

07-2004

THE ROLE OF APOPTOSIS IN LUNG INFLAMMATION AND INJURY IN THE ROLE OF APOPTOSIS IN LUNG INFLAMMATION AND INJURY IN

ALPHA ONE FO

06-2004

ALPHA-1 FOUNDATION DNA and TISSUE BANK ALPHA-1 FOUNDATION DNA and TISSUE BANK

ALPHA ONE FO

06-2004

STATE OF FLORIDA ALPHA 1 DETECTION PROGRAM UNDER STATE O STATE OF FLORIDA ALPHA 1 DETECTION PROGRAM UNDER STATE O

ALPHA ONE FO

06-2004

THE PHARMACOKINETICS AND SAFETY OF AN ALPH-1 PROTEINASE THE PHARMACOKINETICS AND SAFETY OF AN ALPH-1 PROTEINASE

CROFESSIONAL

05-2004

UNIVERSITY OF FLORIDA ALPHAL- ANTITRYPSIN DEFICIENCY LAB UNIVERSITY OF FLORIDA ALPHAL- ANTITRYPSIN DEFICIENCY LAB

ALPHA ONE FO

05-2004

ALPHA-1 ANTITRYPSIN DEFICIENCY LABORATORY ALPHA-1 ANTITRYPSIN DEFICIENCY LABORATORY

ALPHA ONE FO

04-2004

COMPARATIVE MICROARRAY ANALYSIS OF GLOBAL LIVER GENE EXP COMPARATIVE MICROARRAY ANALYSIS OF GLOBAL LIVER GENE EXP

ALPHA ONE FO

08-2003

COPD AND AN INVESTIGATIONAL DRUG BY AMGEN COPD AND AN INVESTIGATIONAL DRUG BY AMGEN

AMGEN IN

06-2003

MOLECULAR THERAPIES FOR ALPHA 1-ANTITRYPSIN LIVER DISEAS MOLECULAR THERAPIES FOR ALPHA 1-ANTITRYPSIN LIVER DISEAS

ALPHA ONE FO

06-2003

CHARACTERIZATION OF LOWER RESPIRATORY TRACT INHIBITION CHARACTERIZATION OF LOWER RESPIRATORY TRACT INHIBITION

BERBECKER, WJ AND LA SCHOLAR FO

05-2003

ALPHA ONE FOUNDATION SUBCONTRACT FOR STATE OF FLORIDA ALPHA ONE FOUNDATION SUBCONTRACT FOR STATE OF FLORIDA

ALPHA ONE FO

02-2003

ALPHA-1 ANTITRYPSIN DEFICIENCY LABORATORY ALPHA-1 ANTITRYPSIN DEFICIENCY LABORATORY

ALPHA ONE FO

07-2002

RESEARCH NURSE SALARY RESEARCH NURSE SALARY

AVENTIS BEHRIN

05-2002

AAT MATCHING FUNDS AAT MATCHING FUNDS

ALPHA ONE FO

03-2002

RNDMZD CNTRL MULTI-CTR STDY TO COMPARE THE BIOCHEMICAL E RNDMZD CNTRL MULTI-CTR STDY TO COMPARE THE BIOCHEMICAL E

AVENTIS BEHRIN

03-2002

SUPPLEMENTAL FUNDS (IV STUDY) FOR LAB SERV AGREE TO PERF SUPPLEMENTAL FUNDS (IV STUDY) FOR LAB SERV AGREE TO PERF

AVENTIS BEHRIN

01-2002

DBL-BL RNDMZD PLCB-CNTRL DOSE ESCALATION STDY TO ASSES T DBL-BL RNDMZD PLCB-CNTRL DOSE ESCALATION STDY TO ASSES T

AVENTI

10-2001

STUDY TO ASSESS BIOCHEMICAL MARKERS IN EPITHELIAL LINING STUDY TO ASSESS BIOCHEMICAL MARKERS IN EPITHELIAL LINING

PPL THERAPEUTIC

12-2000

VENTIS BEHRING (CENTEON) LABORATORY TESTING AGREEMENT VENTIS BEHRING (CENTEON) LABORATORY TESTING AGREEMENT

AVENTI

05-2000

AUGMENTATION THERPY FOR CONGENITAL ALPHA1-PROTEINASE AUGMENTATION THERPY FOR CONGENITAL ALPHA1-PROTEINASE

ALPHA THERAPEUTIC COR

08-1999

RNDMZD CONTRLD MULTI-CTR STDY TO COMPAR THE BIOCHEMICAL RNDMZD CONTRLD MULTI-CTR STDY TO COMPAR THE BIOCHEMICAL

CENTEO

Publications

Search Google Scholar for Mark Brantly

OpenAlex Works Search

More Publications

"Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis"

2019 ▪ European Respiratory Journal

Jeffrey P Krischer; Francis X. McCormack; Yoshikazu Inoue; Joel Moss; Lianne G. Singer; Charlie Strange; Koh Nakata; Alan F. Barker; Jeffrey T. Chapman; Mark L. Brantly; James M. Stocks; Kevin K. Brown; Joseph P. Lynch; Hilary J. Goldberg; Lisa R. Young; Gregory P. Downey; Angelo M. Taveira-DaSilva; Bruce C. Trapnell; Hye-Seung Lee; Nishant Gupta; Kenneth Setchell;

https://openalex.org/W2921455439
"Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases"

2014 ▪ Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation

Jeffrey P Krischer; Christopher S. Coffey; Charlie Strange; Mark L. Brantly; Stephen C. Groft; Robert A. Sandhaus; Adam Wanner; J. Russell Teagarden; Barry Davis; David Hickam; Jeffrey Teckman; David Nelson; Michael McCaleb; Rohit Loomba; Jonathan Edelman; Albert Farrugia;

https://openalex.org/W2182300165
"Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial"

2013 ▪ The Lancet Respiratory Medicine

Jeffrey P Krischer; Francis X. McCormack; Yoshikazu Inoue; Joel Moss; Lianne G. Singer; Charlie Strange; Koh Nakata; Alan F. Barker; Jeffrey T. Chapman; Mark L. Brantly; James M. Stocks; Kevin K. Brown; Joseph P. Lynch; Hilary J. Goldberg; Lisa R. Young; Gregory P. Downey; Angelo M. Taveira-DaSilva; Hye Seung Lee; Bruce C. Trapnell; Jeffrey J Swigris;

https://openalex.org/W2146421823
"Baseline Serum VEGF-D Levels Are Associated With Disease Severity And Treatment Response In Lymphangioleiomyomatosis"

2011 ▪

Jeffrey P Krischer; Francis X. McCormack; Yoshikazu Inoue; Joel Moss; Lianne G. Singer; Charlie Strange; Koh Nakata; Jeffrey T. Chapman; Mark L. Brantly; James M. Stocks; Kevin K. Brown; Joseph P. Lynch; Hilary J. Goldberg; Lisa R. Young; Brent W. Kinder; Gregory P. Downey; Eugene J. Sullivan; Thomas V. Colby; Roy T. McKay; Marsha M. Cohen; Leslie Korbee; Angelo M. Taveira-DaSilva; Bruce C. Trapnell; Hye-Seung Lee; Alan Barker;

https://openalex.org/W2324576299
"Multicenter International Lymphangioleiomyomatosis Efficacy And Safety Of Sirolimus (MILES) Trial"

2011 ▪

Jeffrey P Krischer; Francis X. McCormack; Yoshikazu Inoue; Joel Moss; Lianne G. Singer; Charlie Strange; Koh Nakata; Jeffrey T. Chapman; Mark L. Brantly; James M. Stocks; Kevin K. Brown; Joseph P. Lynch; Hilary J. Goldberg; Lisa R. Young; Brent W. Kinder; Eugene J. Sullivan; Thomas V. Colby; Roy T. McKay; Marsha M. Cohen; Leslie Korbee; Angelo M. Taveira-DaSilva; Hye Seung Lee; Bruce C. Trapnell; Alan Barker;

https://openalex.org/W2324694366
"Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis"

2011 ▪ New England Journal of Medicine

Jeffrey P Krischer; Francis X. McCormack; Yoshikazu Inoue; Joel Moss; Lianne G. Singer; Charlie Strange; Koh Nakata; Alan F. Barker; Jeffrey T. Chapman; Mark L. Brantly; James M. Stocks; Kevin K. Brown; Joseph P. Lynch; Hilary J. Goldberg; Lisa R. Young; Brent W. Kinder; Gregory P. Downey; Eugene J. Sullivan; Thomas V. Colby; Roy T. McKay; Marsha M. Cohen; Leslie Korbee; Angelo M. Taveira-DaSilva; Hye Seung Lee; Bruce C. Trapnell;

https://openalex.org/W2147028601

Co-Investigator Network

Josephine Allen

University of Florida

EG-MATERIALS SCI ENGINEERING, College-Engineering

jallen@mse.ufl.edu

Inactive Expert

Veena Antony

NLE

University of Florida

MD-PULMONARY MEDICINE, College-Medicine

antonvb@medicine.ufl.edu

Aaron Aponick

Professor

University of Florida

LS-CHEMISTRY-GENERAL, College-Liberal Arts/Sciences

aponick@chem.ufl.edu

Inactive Expert

Wajeeh Bajwa

Director Regulatory Knowledge and Support Program

University of Florida

Clinical and Translationsal Science Institutue (CTSI), Clinical And Translationsal Science Institutue (Ctsi)

wajeeh.bajwa@gmail.com

Christopher Batich

PROF

University of Florida

EG-MATERIALS SCI ENGINEERING, College-Medicine And Engineering

cbati@ufl.edu

Inactive Expert

Maher Baz

University of Florida

MD-PULMONARY-TRANSPLANT, College-Medicine

Thomas Beaver

Professor

University of Florida

Surgery, College Of Medicine

thomas.beaver@surgery.ufl.edu

Inactive Expert

Edward Block

DSP & CHR

University of Florida

MD-RHEUMATOLOGY, College-Medicine

blocker@medicine.ufl.edu

Inactive Expert

Fernando Bril

University of Florida

MD-MED CENTRAL-HOUSESTAFF, College-Medicine

fernando.bril@gmail.com

Andrew Bryant

University of Florida

MD-PULMONARY MEDICINE, College-Medicine

andrew.bryant@medicine.ufl.edu

Carma Bylund-Lincoln

Professor and Associate Chair of Education

University of Florida

MD-HOBI-GENERAL, College-Medicine

carma.bylund@ufl.edu

Michelle Cardel

Senior Director, Global Clinical Research & Nutrition WW International, Inc; Adjunct Professor, Department of Health Outcomes & Biomedical Informatics; Associate Director, Center for Integrative Cardiovascular and Metabolic Disease

University of Florida

MD-HOBI-GENERAL, College-Medicine

mcardel@ufl.edu

Inactive Expert

Naser Chegini

PROFESSOR

University of Florida

MD-OBGYN-WOUND RESEARCH CTR, College-Medicine

cheginin@obgyn.ufl.edu

Inactive Expert

Xinguang Chen

Professor of Epidemiology

University of Florida

PHHP-COM EPIDEMIOLOGY, Phhp-Com Integrated Programs

jimax.chen@ufl.edu

Inactive Expert

Michael Clare-Salzler

Professor Emeritus

University of Florida

MD-SURGERY, College-Medicine

salzler@ufl.edu

Rhonda Cooper-DeHoff

Associate Professor

University of Florida

PH-PHARMTHERAPY TRNSL RSCH, College-Pharmacy

dehoff@cop.ufl.edu

Kristin Dayton

Associate Professor

University of Florida

MD-PEDS-ENDOCRINOLOGY, College-Medicine

kristinjohnson23@peds.ufl.edu

Inactive Expert

Anna De Benedetto

Clinical Associate Professor

University of Florida

VM-SACS, College-Veterinary Med

adebenedetto@dermatology.med.ufl.edu

Inactive Expert

Hartmut Derendorf

Distinguished Professor Emeritus (Deceased)

University of Florida

PH-OFFICE OF THE DEAN, College-Pharmacy

hartmut@ufl.edu

Inactive Expert

Gill Diamond

Professor

University of Florida

DN-ORAL BIOLOGY, College-Dentistry

gdiamond@ufl.edu

Inactive Expert

Lisa Domenico

Assistant Professor

University of Florida

MD-CTSI CLIN AND TRAN SCI INST, College-Medicine

ldomenico@ufl.edu

William Donahoo

CHIEF & CLIN PROF

University of Florida

MD-ENDOCRINOLOGY, College-Medicine

wdonahoo@ufl.edu

Inactive Expert

Leylah Drusbosky

University of Florida

MD-CTSI CLIN AND TRAN SCI INST, College-Medicine

Natalie Ebner

Professor

University of Florida

LS-PSYCHOLOGY-GENERAL, College-Liberal Arts/Sciences

natalie.ebner@ufl.edu

Ibrahim Faruqi

Clinical Associate Professor

University of Florida

MD-PULMONARY MEDICINE, College-Medicine

ibrahim.faruqi@medicine.ufl.edu

David Fedele

Associate Professor & Child/Pediatric Area Head

University of Florida

MD-PEDS-PULMONARY, College-Medicine

dfedele@ufl.edu

Leonardo Ferreira

Associate Professor

University of Florida

HH-APK-ADMINISTRATION, College-Hlth/Human Performance

ferreira@hhp.ufl.edu

Inactive Expert

Terence Flotte

EM SCH & CHR

University of Florida

MD-NEUROSCIENCE-GENERAL, College-Medicine

flotttr@peds.ufl.edu

Inactive Expert

Regino Gonzalez-Peralta

PROFESSOR

University of Florida

MD-PEDS-GASTROENTEROLOGY, College-Medicine

regino@peds.ufl.edu

Yi Guo

Associate Professor

University of Florida

MD-HOBI-GENERAL, College-Medicine

yiguo@ufl.edu

Matthew Gurka

Professor and Director, Pediatrics Research Hub (PoRCH)

University of Florida

MD-PEDIATRICS, College-Medicine

matthewgurka@ufl.edu

Inactive Expert

Eloise Harman

PROF & PRG DIR

University of Florida

MD-PEDS-CRITICAL CARE DIVISION, College-Medicine

Karen Hegland

Research Assistant Professor

University of Florida

VM-PHY SCI, College-Veterinary Med

kwheeler@ufl.edu

Coy Heldermon

Associate Professor

University of Florida

MD-HEMATOLOGY/ONCOLOGY, College-Medicine

coy.heldermon@medicine.ufl.edu

Inactive Expert

Amanda Hicks

Assistant Professor

University of Florida

DEPARTMENT OF HEALTH OUTCOMES AND BIOMEDICAL INFORMATICS, College-Medicine

aehicks@ufl.edu

Inactive Expert

Hanbo Hu

Assistant Scientist

University of Florida

MD-PULMONARY-TRANSPLANT, College-Medicine

hanbohu@ufl.edu

Inactive Expert

Zhiguang Huo

Assistant Professor

University of Florida

PHHP-COM BIOSTATISTICS, Phhp-Com Integrated Programs

xiaoguang1988@gmail.com

Andrew Judge

Professor

University of Florida

HP-PHYSICAL THERAPY, College-Publ Hlth / Hlth Profs

arjudge@ufl.edu

Frederic Kaye

Professor

University of Florida

MD-MOLECULAR GENTCS / MICROBIO, College-Medicine

fkaye@ufl.edu

Nazli Khodayari

Assistant Professor

University of Florida

MD-PULMONARY MEDICINE, College-Medicine

nazlikhodayari@ufl.edu

Inactive Expert

Joyce Koenig

ASO PROFESSOR

University of Florida

MD-PEDS-NEONATOLOGY, College-Medicine

koenijm@ufl.edu

Janice Krieger

Director, Associate Professor

University of Florida

Advertising, College Of Journalism And Communications

janicekrieger@jou.ufl.edu

Samsun Lampotang

Joachim S. Gravenstein Professorship Of Anesthesiology; Director, CSSALT; Director, Innovations Director, Office Of Educational Affairs/Office Of Medical Education; Joint Professor Of Urology

University of Florida

MD-ANESTHESIOLOGY-GENERAL, College-Medicine

slampotang@anest.ufl.edu

Jungnam Lee

Assistant Research Professor

University of Florida

MD-PULMONARY MEDICINE, College-Medicine

jungnam.lee@medicine.ufl.edu

Jada Lewis

Chair of Physiological Sciences, Professor of Physiological Sciences and Neuroscience

University of Florida

MD-NEUROSCIENCE-GENERAL, College-Medicine

jada.lewis@ufl.edu

Mark Lewis

Professor

University of Florida

MD-PSYCHIATRY, College-Medicine

marklewis@ufl.edu

Inactive Expert

Chen Liu

Professor

University of Florida

MD-PATHOLOGY, College-Medicine

liu@pathology.ufl.edu

Carol Mathews

Donald R Dizney Chair And Professor, Department Of Psychiatry

University of Florida

MD-PSYCHIATRY, College-Medicine

carolmathews@ufl.edu

Borna Mehrad

Chief and Professor

University of Florida

MD-PULMONARY MEDICINE, College-Medicine

emma.dyer@medicine.ufl.edu

Duane Mitchell

Director - UF Clinical and Translational Science Institute; Assistant Vice President for Research - University of Florida; Associate Dean - UF College of Medicine

University of Florida

MD-NEUROLOGICAL SURGERY, College-Medicine

duane.mitchell@neurosurgery.ufl.edu

Amy Mobley

University of Florida

HH-HEB-ADMINISTRATION, College-Hlth/Human Performance

amy.mobley@mail.ufl.edu

Francois Modave

Assistant Dean, Quality and Patient Safety Initiative (QPSi), Academy, Training, and Fellowship Programs, Professor of Artificial Intelligence, Associate Chair for Research, Department of Anesthesiology

University of Florida

MD-ANESTHESIOLOGY-GENERAL, College-Medicine

modavefp@ufl.edu

David Nelson

Senior Vice President for Health Affairs, UF & President, UF Health

University of Florida

HA-EXECUTIVE, Office Of Health Affairs

nelsodr@ufl.edu

Inactive Expert

Tiago Noguchi Machuca

Chief of the Division of Thoracic Surgery

University of Florida

MD-SURGERY-THORACIC, College-Medicine

tiago.machuca@surgery.ufl.edu

David Ostrov

Associate Professor

University of Florida

MD-PATHOLOGY, College-Medicine

ostroda@ufl.edu

Tezcan Ozrazgat Baslanti

Research Assistant Professor

University of Florida

MD-MED QUANTITATIVE HEALTH, College-Medicine

tezcan@ufl.edu

Inactive Expert

J Patel

PROFESSOR

University of Florida

MD-PULMONARY-TRANSPLANT, College-Medicine

pateljm@medicine.ufl.edu

Thomas Pearson

University of Florida

PHHP-COM EPIDEMIOLOGY, Phhp-Com Integrated Programs

tapearson@ufl.edu

Emily Plowman

Professor, Department of Surgery - Division of Cardiovascular Surgery

University of Florida

MD-SURGERY-TCV-CARDIOVASC, College-Medicine

eplowman@phhp.ufl.edu

Catherine Price

Associate Professor

University of Florida

HP-CLINICAL / HLTH PSYCHOLOGY, College-Publ Hlth / Hlth Profs

cep23@phhp.ufl.edu

Rene Przkora

Professor Of Anesthesiology; Chief, Pain Medicine Division; Director, Multidisciplinary Pain Medicine Fellowship, Interim Associate Chair for Research

University of Florida

MD-ANEST-CHRONIC PAIN MED, College-Medicine

rprzkora@anest.ufl.edu

Inactive Expert

Melissa Ralston

University of Florida

MD-PEDIATRICS, College-Medicine

mbright@coe.ufl.edu